LivOnyx co-founder. Former research scientist at Cubist Pharmaceuticals with expertise working with Clostridium difficile. Nationally recognized as a STEM Ed ambassador.
B.S. & M.S., Microbiology, University of NH
LivOnyx co-founder. Specializes in designing, making and testing consumables and hardware for the biomedical and life science fields.
Ph.D., Materials Science & Engineering, MIT
LivOnyx co-founder. Principal & Founder of ZIP Innovations a research, design strategy and innovation consultancy. Former principal at IDEO.
B.S., Product Design / Mechanical Engineering, Stanford University
Clinical microbiologist with experience in research microbiology focused on antibiotic discovery and infection prevention.
B.S. Medical Laboratory Science with Minor in Microbiology, University of New Hampshire
Advisors
Mike Bonney
Executive Leader and
Business advisor.
Current executive Chairman of Kaleido Biosciences and former CEO of Cubist Pharmaceuticals.
Ronald (Ronnie) Farquhar, Ph.D.
Scientific, Entrepreneurial
and Business advisor.
Current Entrepreneur in Residence and startup CEO at Artugen Therapeutics, former SVP of Discovery and Pharmaceutical Sciences
Praveen Tipirneni, M.D.
Business/Corporate
Development, Strategy
and Clinical advisor.
Current CEO of Morphic Therapeutic, former SVP of Corporate Development and Global Strategy at Cubist Parmaceuticals.
Brad Prosek
Business/Corporate
Development, Commercial
and Strategy advisor.
Current SVP of Corporate Development at Constellation Pharmaceuticals and former Head of Infection Prevention at Cubist.